If you see the message that your project is not enabled for the UK Biobank Research Analysis Platform (UKB‑RAP), it usually means that one or more access requirements have not yet been completed. Please check that all the following requirements have been met:
-
Mandatory training: The Principal Investigator (PI) and Lead Collaborators must have completed all four mandatory training modules:
- Introduction to using UK Biobank
- Introduction to the UK Biobank Research Analysis Platform
- Code Repository
- MRC course: “Research, GDPR & Confidentiality”
Completion dates must be visible on each relevant researcher’s profile in the Access Management System (AMS).
- Material Transfer Agreement (MTA): The latest MTA must be signed and fully executed.
- Payment: UK Biobank must have received payment covering the data tier requested for the project.
- Project status: The project must be marked as “Underway” in AMS. An application marked as “Approved” is not yet enabled for UKB-RAP access.
If you previously had access but can no longer access your project, please check the following:
- Project expiry: If your project has lapsed, you will need to submit a duration extension request to continue accessing the data.
- Change review: A project change request may temporarily pause access until the review is complete.
- Annual report: An overdue annual report may affect access. Please check that your latest report has been submitted.
- Registration recheck: Your researcher registration may be awaiting review. Please allow the Access team time to complete this.
- Date of birth: Check that your date of birth is recorded in your AMS profile. If it is missing, please add it and allow time for any resulting registration recheck.
Once all requirements have been met and access has been enabled, please wait until the following working day before attempting to dispense data to your project.
Still seeing ‘The application is not enabled for UKB-RAP’?
If all requirements have been met and you still encounter this error, raise a Support Ticket.
Related to
Comments
0 comments
Article is closed for comments.